Cambodia-
India
Kazakhstan
Kenya
Malaysia
Moldova
Myanmar
Philippines
Tajikistan
Ukraine
Uzbekistan
Vietnam
Cambodia
India
Kazakhstan
Kenya
Malaysia
Moldova
Myanmar
Philippines
Tajikistan
Ukraine
Uzbekistan
Vietnam
Our profound commitment to improving the lives of patients globally guides every aspect of our manufacturing operations. We take the responsibility of making and delivering quality medicine very seriously. We have been successfully manufacturing a large variety of medication in various dosage form for over two decades. In recent years we have extended our expertise into the production of effervescents, injectibles and suppositories and have fully integrated their seamless production in our manufacturing infrastructure.
Our success is a direct factor of excellence in several critical areas. Our in-house R & D development team continually advances our understanding of formulations and the process technology that are both critical to improving our capabilities and output.
Our manufacturing units are equipped with state of the art equipment and cutting-edge technologies to meet the demand for our existing & new formulations. Thorough business continuity planning provides redundancy on a global level to ensure product availability while minimising the impact on the environment by limiting waste and using resources efficiently.
Read MoreOur quality team manages compliance and supervises consistent and dependable production of our formulations, while our supply chain ensures timely delivery to patients, when and where they need them. This enables us to manufacture and supply high-quality medicines to patients in over 25 countries. As we advance, we aim to increase our production capabilities by focusing on newer products and the adoption of more modern production techniques.
Responsible for implementation of Quality Systems across the organization to ensure Quality products.
Ensures the quality accuracy of each product manufactured by testing using state-of-the-art instrumentation and highly qualified.
We have a state-of-art Formulation & Development Facility, designed for developing innovative research techniques and unique.
We have a state of art Formulation & Development facility, designed for developing innovative research techniques and unique therapeutic approaches for producing finished dosage forms. Formulation & Development centre is well-equipped for the development of various solid, semi-solid and liquid dosage forms.
There is a dedicated team of highly qualified scientists possessing substantial experience and expertise in the area of formulation & development and technology transfer of products. Team utilizes the concept of quality by design, data driven decision and risk assessment for all operations. Superior performance is reflected by success in developing niche of patent products and new technologies affording better medicines to patients.
Read More
Kusum’s Research & Development Facility is equipped with world-class infrastructure and industry leading manpower, developing various solid dosage forms along with the capability to handle semi-solid and liquid dosage forms.
We have a specialized team which spearheads research in the development of market-specific products. Our development team possess substantial experience and expertise in the area of formulation & development and transfer of technology of developed products. Our key focus areas are Immediate Release, Modified Release & Sustained Release Formulations.
Read More
A regulatory team is in place to prepare and compile all the documentations required to register products in various geographic locations and to answer the queries raised time to time by the concerned registration authorities.
Pharmaceutical products are subject to regulations designed by governments to protect public health. The Regulatory Affairs departments of Kusum Healthcare ensure that company complies with all of the regulations and laws concerning business. The Regulatory Affairs department is an important part of the organizational structure in Kusum Healthcare. Internally it liaises at the interface of drug development, manufacturing, marketing and clinical research Externally.
Read More